Healthcare
Auctus
Coming January 06, 2026
Auctus Vertical Body Tethering has received a Breakthrough Device Designation and Humanitarian Device Exemption Pathway from the FDA
Auctus Vertical Body Tethering has received a Breakthrough Device Designation and Humanitarian Device Exemption Pathway from the FDA
Auctus Vertical Body Tethering has received a Breakthrough Device Designation and Humanitarian Device Exemption Pathway from the FDA
BrainScope has a pipeline that spans stroke, Alzheimer’s, concussion, and beyond, and is uniquely positioned in a $21B+ global market
Breakthru Medicine is developing precision cancer therapies targeting an $18B+ solid cancer market with massive unmet need
Auctus Vertical Body Tethering has received a Breakthrough Device Designation and Humanitarian Device Exemption Pathway from the FDA
General Oncology, Inc., is advancing late-stage oncology and ophthalmology programs with human proof-of-concept data and a defined path to liquidity.
BrainScope has a pipeline that spans stroke, Alzheimer’s, concussion, and beyond, and is uniquely positioned in a $21B+ global market
Hummingbird Tympanostomy Tube System enables ear tube placement for children at a doctor’s office in just minutes, dramatically reducing healthcare costs
Hummingbird Tympanostomy Tube System enables ear tube placement for children at a doctor’s office in just minutes, dramatically reducing healthcare costs
General Oncology, Inc., is advancing late-stage oncology and ophthalmology programs with human proof-of-concept data and a defined path to liquidity.
Araceli’s ultra-high-throughput imaging platform is poised to become the backbone of AI-driven drug discovery and therapeutics.
Araceli’s ultra-high-throughput imaging platform is poised to become the backbone of AI-driven drug discovery and therapeutics.